Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
Conditions
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Biphenotypic Acute Leukemia
- Undifferentiated Leukemia
- Prolymphocytic Leukemia
- Myelodysplastic Syndromes
- Chronic Myelogenous Leukemia
- Myeloproliferative Neoplasm
- Relapsed Large Cell Lymphoma
- Mantle Cell Lymphoma
- Hodgkin Lymphoma
- Burkitt Lymphoma
- Relapsed T-Cell Lymphoma
- Relapsed Chronic Lymphocytic Leukemia
- Relapsed Small Lymphocytic Lymphoma
- Relapsed Marginal B-cell Lymphoma
- Relapsed Follicular Lymphoma
- Lymphoplasmacytic Lymphoma
Interventions
- DRUG: Fludarabine
- DRUG: Melphalan
- RADIATION: Total Body Irradiation
Sponsor
H. Lee Moffitt Cancer Center and Research Institute